Fasoracetam

CAS No. 110958-19-5

Fasoracetam( —— )

Catalog No. M22030 CAS No. 110958-19-5

Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 59 In Stock
25MG 111 In Stock
50MG 167 In Stock
100MG 248 In Stock
200MG 357 In Stock
500MG 601 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fasoracetam
  • Note
    Research use only, not for human use.
  • Brief Description
    Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
  • Description
    Fasoracetam is a modulator of GABA receptor potentially for the treatment of attention deficit hyperactivity disorder.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GABA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    110958-19-5
  • Formula Weight
    196.25
  • Molecular Formula
    C10H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (1273.89 mM)
  • SMILES
    O=C([C@H]1CCC(=O)N1)N1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Elia J , Ungal G , Kao C , et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling[J]. Nature Communications, 2018, 9(1).
molnova catalog
related products
  • Leu-Leu-ome hydrochl...

    Leu-Leu-ome hydrochloride?is a lysosomal condensation product that cytotoxic towards natural killer cells and CD4+ and CD8+ T lymphocytes.

  • Cbl-b-IN-5

    Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.

  • WJ460

    WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.